The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $62.45, representing a -0.3% change from its previous close.
In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Viking Therapeutics (VKTX – Research Report). The ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Viking ...